Skip to main content
. 2021 Apr 22;18(11):2449–2456. doi: 10.7150/ijms.58452

Table 1.

Demographic and biochemical characteristics between COPD patients and control subjects

Variables COPD (n=180) Control (n=180) P
Age (years) 74.0 (68.5, 82.0) 67.0 (50.3, 79.6) 0.437
Male, n (%) 132 (73.2) 114 (63.2) 0.351
Hospital stay (day) 10.0 (7.0, 14.0) N.S. N.S.
WBC (109/L) 6.79 (5.07, 9.52) 5.32 (4.32, 6.93) <0.01
Neutrophils (109/L) 4.74 (3.38, 7.22) 3.15 (2.21, 3.96) <0.01
Lymphocyte (109/L) 1.08 (0.78, 1.45) 2.15 (1.72, 2.63) <0.01
Monocyte (109/L) 0.47 (0.33, 0.68) 0.35 (0.29, 0.44) <0.05
CRP (μg/mL) 88.3±9.6 36.5±7.4 <0.01
TNF-α (ng/mL) 103.5±7.9 30.3±6.2 <0.01
IL-6 (pg/mL) 48.6±10.6 19.6±7.6 <0.05
MCP-1 (pg/mL) 206.5±42.5 58.6±7.6 <0.01
FVC (L) 1.88 (1.36, 2.47) N.S. N.S.
FEV1 (%) 40.4 (27.6, 64.8) N.S. N.S.
FEV1/FVC (%) 51.3 (43.3, 58.5) N.S. N.S.